Example: Heart Attack

Clinical Trials on Psoriasis

Total 1702 results

NCT04535999

Not yet recruiting

Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)

Conditions: Psoriasis
NCT03848806

Completed

Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

Conditions: Psoriasis
NCT03988439

Recruiting

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Conditions: Psoriasis
NCT03987763

Recruiting

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Conditions: Psoriasis
NCT03518047

Completed

Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation

Conditions: Psoriasis
NCT03478787

Completed

Risankizumab Versus Secukinumab for Subjects With Moderate to Severe Plaque Psoriasis

Conditions: Psoriasis
NCT04250792

Completed

Efficacy of Low Dose Naltrexone in Psoriasis

Conditions: Psoriasis
NCT02707341

Enrolling by invitation

The Corrona Psoriasis (PSO) Registry

Conditions: Psoriasis
NCT04102241

Active, not recruiting

Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Conditions: Psoriasis
NCT03475914

Completed

Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis

Conditions: Psoriasis
NCT02622386

Suspended

The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

Conditions: Psoriasis
NCT02995473

Completed

Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis

Conditions: Psoriasis
NCT03392168

Completed

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Conditions: Psoriasis
NCT01989689

Completed

Etanercept and Vascular Function in Psoriasis

Conditions: PSORIASIS
NCT03850483

Recruiting

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Conditions: Psoriasis
NCT03960450

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis

Conditions: Psoriasis
NCT02940002

Completed

BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

Conditions: Psoriasis
NCT03403036

Completed

Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies

Conditions: Psoriasis
NCT02888236

Completed

LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Conditions: Psoriasis Vulgaris
NCT03875508

Completed

A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

Conditions: Psoriasis
NCT03131570

Active, not recruiting

Safety and Efficacy of Secukinumab in Mild Psoriasis

Conditions: Psoriasis
NCT03875482

Completed

A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis

Conditions: Psoriasis
NCT03482011

Completed

A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis

Conditions: Psoriasis
NCT03469336

Completed

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Conditions: Psoriasis
NCT02417792

Completed

The Association Between Psoriasis and Intestinal Bacterial Population

Conditions: Psoriasis